Table 1.
Demographic and Clinical Characteristics of ARTI Patients with Respiratory Pathogen Detection.
| No. (%) of Tested (N = 5142) | ||
|---|---|---|
| MRP Assay | ||
| Luminex | 1264 (24.6%) | |
| Biofire | 3878 (75.4%) | |
| Age at Admission | ||
| <90 days | 819 (15.9%) | |
| 3-24 months | 2077 (40.4%) | |
| 2+ years | 2246 (43.7%) | |
| Organism | ||
| Any Bacterial Organism a | 110 (2.1%) | |
| Rhino/Entero | 2518 (49.0%) | |
| Influenza | 237 (4.6%) | |
| RSV | 706 (13.7%) | |
| Metapneumo | 344 (6.7%) | |
| Coronavirus | 134 (2.6%) | |
| Parainfluenza | 322 (6.3%) | |
| Adenovirus | 191 (3.7%) | |
| Viral Co-detection | 580 (11.3%) | |
| Location of MRP Order | ||
| PICU | 151 (2.9%) | |
| ED | 1439 (28.0%) | |
| Med/Surg | 3301 (64.2%) | |
| Other/Unknown | 251 (4.9%) | |
| Calendar Quarter of Order | ||
| Q1 | 1840 (35.8%) | |
| Q2 | 1193 (23.2%) | |
| Q3 | 1027 (20.0%) | |
| Q4 | 1082 (21.0%) | |
a
Includes M. pneumoniae, C. pneumoniae, andB. pertussis.